Cavid Baba

The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?

Sedat Şen, Rana Karabudak, Irene Schiavetti et al. · Multiple Sclerosis and Related Disorders · 2021 · 24 citations · Full text

Life Sciences, Infectious Diseases, Internal Medicine +5

The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis

Cavit Boz, Serkan Özakbaş, Murat Terzi et al. · Neurological Sciences · 2023 · 22 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +10

Comparison of SARS-CoV-2 antibody response after two doses of mRNA and inactivated vaccines in multiple sclerosis patients treated with disease-modifying therapies

Serkan Özakbaş, Cavid Baba, Yavuz Doğan et al. · Multiple Sclerosis and Related Disorders · 2022 · 21 citations · Full text

Veterinary Medicine, Immunology, Neurology +13

Prevalence and determinants of falls in persons with multiple sclerosis without a clinical disability

Zuhal Abasıyanık, Turhan Kahraman, Özge Ertekin et al. · Multiple Sclerosis and Related Disorders · 2021 · 20 citations

Medicine, Neurology, Rehabilitation Medicine +13

Effects and safety of exergaming in persons with multiple sclerosis during corticosteroid treatment: a pilot study

Asiye Tuba Özdoğar, Cavid Baba, Turhan Kahraman et al. · Multiple Sclerosis and Related Disorders · 2022 · 19 citations

Life Sciences, Internal Medicine, Neurology +7